Everything Everywhere Daily: History, Science, Geography & More - Organ Transplants

Starting point is 00:00:00 For most of human history, when a vital body part failed, there was little the doctors could do. Then a series of advances in surgery, immunology, and pharmaceuticals made something that was once considered impossible, increasingly routine. It required solving problems of compatibility, rejection, preservation, and advanced surgical techniques. And today, tens of thousands of people a year owe their lives to this breakthrough. Learn more about the history of organ transplants and how they work on this episode of Everything Everywhere Daily. New from Nespresso. Blend wellness into your coffee routine with a coffee plus range, infused with functional

Starting point is 00:00:51 benefits. Choose the coffee you love with added B vitamins, like coffee plus B12 to help support immune function, and coffee plus B6 to keep your day moving. Or go with the flow and choose ginseng delight. Our new double espresso with ginseng extract. Whatever lies ahead, don't change your morning. Let your morning change you. Discover Coffee Plus on Nespresso.com.

Starting point is 00:01:14 You gotta try breakfast. And what better way than with a delicious pratt organic coffee? Starting with just $1 all day, every day now until December 31st. You gotta try breakfast at A&W. I participating in W locations in Ontario. Organ transplantation is one of medicine's most remarkable achievements, because it required solving several problems that were all once considered to be impossible. Organ transplants are conceptually simple to understand. It's simply replacing a failing organ with a

Starting point is 00:02:03 functioning organ taken from another person, or in experimental cases, even from another species. It sounds simple, but solving the problem of organ transplantation required multiple medical breakthroughs, many of which won Nobel Prizes. One major problem was physical and surgical. Surgeons needed to develop techniques that allowed them to connect blood vessels between the organ and the body. The second problem, which was arguably larger, was biological. Transplanted organs are foreign tissue, and the body will often reject them as if they were a foreign pathogen. While organ transplants are relatively recent, the idea is actually quite old.

Starting point is 00:02:47 Ancient myths contain stories of limbs, eyes, hearts, and other body parts being replaced. More practically, ancient Indian physicians develop sophisticated forms of reconstructive surgery. The surgical tradition associated with the Sushutra Samhita, probably compiled during the first millennium BC, described techniques for reconstructing noses using flaps of the patient's own skin. It wasn't organ transplantation per se, but it was transplanting skin, from one part of the body to another. During the Renaissance, the Italian surgeon, Gaspari Tayacozzi, developed techniques for reconstructing noses using skin from a patient's arm. He reportedly recognized that tissue taken from another individual behaved differently and generally failed. By the 19th century,

Starting point is 00:03:36 surgeons experimented systematically with skin grafts. Skin taken from the same person often survived, but skin transferred from another person might initially appear healthy, but usually deteriorated and disappeared. No one yet understood the immune mechanism responsible for rejecting foreign tissue. A solid organ cannot survive unless its blood supply can be restored quickly. That required surgeons to learn how to sew arteries and veins together without causing catastrophic bleeding, narrowing the vessel, or producing blood clots. One of the critical pioneers in this field was the French surgeon Alexei Karel. At the beginning of the 20th century, Karell developed reliable techniques for vascular anastomosis, the surgical joining of blood vessels. He experimented with

Starting point is 00:04:25 transplantation in animals and demonstrated that entire organs could be removed and reconnected to another circulatory system. Karell received the 1912 Nobel Prize in physiology largely for his work in vascular suturing and transplantation. Modern transplantation, would quite literally be impossible without this surgical innovation. Another important advance came from Carl Lannsteiner's discovery of ABO blood types in 1901. Blood transfusions had previously been unpredictable. Some worked while others caused rapid and sometimes fatal reactions. Lansziner demonstrated that people possessed different blood types and that antibodies could

Starting point is 00:05:08 attack incompatible red blood cells. Although organ rejection is considered. more complicated than just blood types, the discovery established an important principle, biological compatibility between people mattered. Lance Diner was awarded the Nobel Prize for his work in 1930. Transplant programs eventually realized that blood type was one of the very first things to consider when matching donors and recipients. One form of transplantation succeeded surprisingly early.

Starting point is 00:05:37 In 1905, Austrian ophthalmologist Edward Zerm, performed what is generally regarded as the first successful corneal transplant. The cornea is unusually favorable for transplantation because it does not contain blood vessels, so it's relatively isolated from much of the immune system. The kidney became the natural experimental organ for transplantation for several reasons. Humans have two kidneys and can normally live with just one, making donation possible. And kidneys have comparatively simple vascular connections. kidney function can also be easily assessed by monitoring urine output and blood chemistry.

Starting point is 00:06:18 Researchers experimented extensively with kidney transplantation in animals during the early 20th century. In 1933, Ukrainian surgeon Yuri Voronov attempted the first human-to-human kidney transplant. The donor was deceased and the recipient suffered from an acute renal failure. The kidney never functioned adequately and the patient died shortly afterwards. The operation was a failure as a treatment, but it demonstrated that human organ transplantation was surgically conceivable. The biological problem, however, remained unsolved. Another step came in 1950 when Chicago surgeon Richard Lawler transplanted a kidney from a deceased donor into a woman suffering from kidney disease. The transplanted kidney was eventually removed after about two months,

Starting point is 00:07:07 but the patient survived because her own kidneys had recovered sufficiently. It wasn't a permanent cure, but it demonstrated the surgical technique could work. By this point, surgeons were becoming capable of performing the operation. The problem was that the immune system kept destroying the organ. The breakthrough came largely from experiments during and after World War II. British biologist Peter Medawar studied skin grafts, partly because severe burns suffered by wartime casualties created an urgent interest in skin transplantation. Metawar demonstrated that graft rejection was not simply the result of poor surgery.

Starting point is 00:07:46 It was an immune response. The first graft from one individual to another might survive temporarily. However, a second graft from the same donor would often be destroyed more rapidly, and that indicated that the recipient's immune system had developed a memory of the donor. The phenomenon became known as acquired immunological tolerance and rejection. Medawar and Australian immunologist Frank McFarlane Burnett later received the 1960 Nobel Prize for work establishing the concept of acquired immunological tolerance. That discovery changed the entire problem.

Starting point is 00:08:24 Doctors no longer simply had to become better surgeons. They had to manipulate the immune system. The first unequivocally successful human, Solid organ transplant occurred on December 23, 1954, at Peter Bent Brigham Hospital in Boston, Massachusetts. The recipient was Richard Herrick, who was dying of kidney disease, and the donor was his identical twin brother, Ronald Herrick. Because identical twins possess essentially the same genetic makeup, Richard's immune system didn't regard his brother's kidney as foreign. Surgeon Joseph Murray headed the recipient operation why Jay Hartwell Harrison performed the donor

Starting point is 00:09:04 kidney removal. The kidney began functioning after transplantation, and Richard Herrick lived for about eight more years. Joseph Murray would share the 1990 Nobel Prize for his work on transplantation. Transplantation between two ordinary people required suppressing the immune system. Early approaches in this were very crude. Researchers experimented with whole body radiation, attempting to destroy enough of the recipient's immune cells to prevent rejection. It sometimes worked, but the treatment could also destroy the bone marrow and leave patients defenseless against other infections. In 1959, kidney transplantation between genetically non-identical people achieved some success using radiation to suppress immunity. The real future lay not in radiation,

Starting point is 00:09:55 but in drugs. One of the first major immunosuppressive drugs was, azathoprene. Asothoprene inhibits the proliferation of rapidly dividing immune cells. By the early 1960s, transplant teams were combining azathoprone with inflammation-reducing corticosteroids such as prednisone. The combination greatly improved kidney transplant survival. In 1962, Murray's Boston Group performed a landmark successful deceased donor kidney transplant using drug-based immunosuppression. That was arguably the moment kidney transplantation began transitioning from experimental surgery into mainstream medicine. Suppressing the immune system certainly helped, but matching compatible donors improved results even further.

Starting point is 00:10:45 Scientists discovered that much of a transplant's rejection revolves around proteins encoded by the human leukocyte antigen system, or HLA. HLA molecules appear on the surface of cells and help the immune system. distinguish the body's own tissue from foreign material. Two unrelated people usually have different HLA profiles. Transplant centers therefore develop tissue typing to compare donor and recipient HLA markers. They also developed what's known as the cross-match test. A cross-match is a compatibility test performed before a transplant. The recipient's blood serum is mixed with the donor cells to see whether the recipient already has antibodies,

Starting point is 00:11:30 that attack the donor's tissue. A positive cross-match usually means that the transplant would carry a high risk of immediate rejection, while a negative cross-match suggests that it's safe to proceed. Put together, blood typing, HLA typing, antibody testing, and cross-matching revolutionized donor selection. The liver presented a much greater surgical challenge than the kidney. It's large, richly supplied with blood vessels and capable of catastrophic bleeding during surgery. American surgeon Thomas Zarl was central to the development of liver transplantation. Zarl performed the first human liver transplant attempt in 1963 at the University of Colorado. The early attempts resulted in short survival and after several failures, the field temporarily

Starting point is 00:12:18 halted liver transplantation while surgical techniques and immunosuppression were improved. In 1967, Zarl's team achieved the first liver transplanted, with significant long-term survival. A 19-month-old girl named Julie Rodriguez survived for more than a year before dying from reoccurring cancer. In December 1966, surgeons William Kelly and Richard Lila Hay

Starting point is 00:12:42 and their colleagues at the University of Minnesota performed the first successful pancreas transplant together with a kidney transplant in a patient that had severe diabetes and kidney failure. Heart transplantation captured far more public attention than kidney or liver transplant. and there were problems that needed to be solved beyond those required for something like a kidney transplant.

Starting point is 00:13:04 Surgeons first needed cardiopulmonary bypass, the heart-lung machine which allow surgeons to stop the heart while a machine temporarily oxygenated and circulated the patient's blood. Techniques developed during open-heart surgery in the 1950s provided much of the necessary surgical knowledge. American surgeon Norman Schumway and his colleagues at Stanford carried out crucial experiments in canine heart transplantation and developed many of the surgical techniques that were ultimately used in humans.

Starting point is 00:13:34 But it was actually another surgeon that reached the milestone first. On December 3, 1967, South African surgeon Christian Bernard and his team at Groucher Hospital in Cape Town, South Africa, performed the world's first human-to-human heart transplant. The recipient was Louis Washkansky,

Starting point is 00:13:53 and the donor was Denise Darval, a young woman who had suffered a catastrophic brain injury in a traffic accident. Washkansky survived the operation and lived for 18 days before dying from pneumonia while heavily immunosuppressed. The short survival might sound disappointing today, but the operation demonstrated that a human heart could be replaced successfully. Lungs proved particularly difficult to transplant. They're constantly exposed to the outside environment through the airway, making infection a serious risk. Bronchial connections must heal properly despite a disrupted blood supply, and lung tissue is especially vulnerable to immune injury. American surgeon James Hardy performed the first human lung transplant

Starting point is 00:14:36 in Mississippi in 1963. The patient survived for only 18 days. A major breakthrough came in 1983 when surgeon Joel Cooper and the Toronto Lung Transplant Group performed a single lung transplant whose recipient survived for years. Many of the advancements over the last few decades have involved improved immunosuppressive drugs. In the 1970s, cyclosporin selectively interfered with T lymphocytes, the immune cells central to transplant rejection, and the effect was dramatic. Instead of broadly destroying a person's immune system, doctors could target just the pathways

Starting point is 00:15:16 involved in rejection much more efficiently. kidney, liver, heart, and eventually lung transplant survival improved dramatically. Another major breakthrough arrived with tachrolomus, which became widely used during the 1990s, especially in liver transplants. Work on organ transplants continues, and exciting new developments are on the horizon. The future of transplantation will likely center on making more organs available and reducing rejection. Major areas include genetically modified pig organs, lab-grown or bio-engineered organs from patients' own cells,

Starting point is 00:15:52 and more precise immune therapies that could eventually reduce or even eliminate the need for lifelong immunosuppressive drugs. Organ transplants have been one of the revolutions of 20th century medicine. However, it wasn't a single innovation. It was a series of advancements across multiple disciplines that improve the lives and lifespans of those who are in need of transplants. The executive producer of Everything Everywhere Daily is Charles Daniel. The associate producers are Austin Otkin and Cameron Kiefer.

Starting point is 00:16:25 My big thanks go to everyone who supports the show over on Patreon. Your support helps make this podcast possible. And I also want to remind everyone about the community groups on Facebook and Discord. That's where everything happens that's outside the podcast. And links to those are available in the show notes. As always, if you leave a review on any major podcast app or in the above community groups, you two can have it read in the show.

Everything Everywhere Daily: History, Science, Geography & More - Organ Transplants

There aren't comments yet for this episode. Click on any sentence in the transcript to leave a comment.